Skip to content

Exercise,Metabolic Syndrome and Weight Regain (Echocardiography Substudy)

Exercise in Patients With Metabolic Syndrome and Weight Regain - Echocardiography Substudy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00543985
Enrollment
36
Registered
2007-10-15
Start date
2007-10-31
Completion date
2008-10-31
Last updated
2017-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Obesity

Keywords

metabolic syndrome, obesity, exercise

Brief summary

We plan to test the hypothesis that patients with metabolic syndrome will have impaired left ventricular diastolic parameters. These parameters will be measured before and after a stress test at the end of a 3 month period of exercise training and a 10% weight loss.

Detailed description

Patients must have 2 of the 5 criteria for metabolic syndrome and be able to exercise in a monitored setting for 45 min 5 times a week.

Interventions

Echocardiography was performs prior to and within 60 seconds of completing the standard Bruce treadmill protocol.

Sponsors

University of Missouri-Columbia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 2 of 5 criteria for metabolic syndrome * Ability to exercise for 45 min 5 days a week

Exclusion criteria

* No diabetes * Established coronary disease

Design outcomes

Primary

MeasureTime frameDescription
Mean Resting E/E'12 weeksE/E' is an echocardiographic parameter where E = early mitral inflow velocity and E' = early diastolic mitral annular motion. Measured in all participants prior to treadmill stress test.
Post-exercise E/E'12 weeksE/E' is an echocardiographic parameter where E = early mitral inflow velocity and E' = early diastolic mitral annular motion. Measured in all participants immediately following treadmill stress test.

Secondary

MeasureTime frameDescription
Mean Resting Maximal Oxygen Uptake (VO2 Max)12 weeksMeasure of the maximum volume of oxygen that a body is capable of utilizing in one minute, measured in milliliters per kilogram of body weight per minute (ml/kg/min). Measured in all participants prior to treadmill stress test.
Change in Maximal Oxygen Uptake (VO2 Max)12 weeksMeasure of the maximum volume of oxygen that a body is capable of utilizing in one minute, measured in milliliters per kilogram of body weight per minute (ml/kg/min) Measured in all participants immediately following treadmill stress test.

Participant flow

Recruitment details

Patients were recruited as part of the parent study on Weight Regain (PI Tom Thomas) funded by NIH. These patients were recruited from clinics, volunteers from advertisements. Patients needed to have 2 of 5 criteria for the Metabolic Syndrome (MetS) plus have obesity.

Pre-assignment details

All patients in this study had successfully been screened as part of the parent study. All patients were to exercise (aerobic) and have a 10% weight loss. Echocardiography was performed prior to and immediately following a maximal stress test at the end of 12 weeks of exercise.

Participants by arm

ArmCount
Stress Echocardiography
Patients completed 3 months of training with 10% weight loss. At the end of that study, they were subjected to pre- and post-stress echocardiography to evaluate E/E' and VO2 max.
32
Total32

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject4

Baseline characteristics

CharacteristicStress Echocardiography
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
32 Participants
Age, Continuous37 years
STANDARD_DEVIATION 2
Gender
Female
15 Participants
Gender
Male
17 Participants
Region of Enrollment
United States
32 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 32
serious
Total, serious adverse events
0 / 32

Outcome results

Primary

Mean Resting E/E'

E/E' is an echocardiographic parameter where E = early mitral inflow velocity and E' = early diastolic mitral annular motion. Measured in all participants prior to treadmill stress test.

Time frame: 12 weeks

Population: The echo results from all subjects were analyzed at rest and following maximal exercise testing.

ArmMeasureValue (MEAN)Dispersion
Stress EchocardiographyMean Resting E/E'7.01 ml/min/kgStandard Error 0.37
Comparison: Pearson Product correlation was used to determine relationships between resting E/E' and Exercise VO2 max and Stress E/E' and Exercise VO2max.p-value: =0.14Regression, Linear
Primary

Post-exercise E/E'

E/E' is an echocardiographic parameter where E = early mitral inflow velocity and E' = early diastolic mitral annular motion. Measured in all participants immediately following treadmill stress test.

Time frame: 12 weeks

Population: The echo results from all subjects were analyzed at rest and following maximal exercise testing.

ArmMeasureValue (MEAN)Dispersion
Stress EchocardiographyPost-exercise E/E'7.41 ml/min/kgStandard Error 0.41
Secondary

Change in Maximal Oxygen Uptake (VO2 Max)

Measure of the maximum volume of oxygen that a body is capable of utilizing in one minute, measured in milliliters per kilogram of body weight per minute (ml/kg/min) Measured in all participants immediately following treadmill stress test.

Time frame: 12 weeks

Population: This data, if analyzed, is unavailable as the PI/study staff left the institution before completing the analysis and without making results available.

Secondary

Mean Resting Maximal Oxygen Uptake (VO2 Max)

Measure of the maximum volume of oxygen that a body is capable of utilizing in one minute, measured in milliliters per kilogram of body weight per minute (ml/kg/min). Measured in all participants prior to treadmill stress test.

Time frame: 12 weeks

Population: This data, if analyzed, is unavailable as the PI/study staff left the institution before completing the analysis and without making results available.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026